These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 20209267)

  • 1. Influence of human T-cell lymphotropic virus type 1 (HTLV-1) Infection on laboratory parameters of patients with chronic hepatitis C virus.
    Cardoso DF; Souza FV; Fonseca LA; Duarte AJ; Casseb J
    Rev Inst Med Trop Sao Paulo; 2009; 51(6):325-9. PubMed ID: 20209267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis C virus and human T-cell lymphotropic virus type 1 co-infection: impact on liver disease, virological markers, and neurological outcomes.
    Espíndola OM; Vizzoni AG; Lampe E; Andrada-Serpa MJ; Araújo AQC; Leite ACC
    Int J Infect Dis; 2017 Apr; 57():116-122. PubMed ID: 28185943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of human T-cell lymphotropic virus I infection on clinical and immunologic outcomes in patients coinfected with HIV and hepatitis C virus.
    Bahia F; Novais V; Evans J; Le Marchand C; Netto E; Page K; Brites C
    J Acquir Immune Defic Syndr; 2011 Aug; 57 Suppl 3(0 3):S202-7. PubMed ID: 21857319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High CD8 T cell percentage and HCV replication control are common features in HIV-1 controllers and HTLV-2-co-infected patients with a history of injection drug use.
    Ruiz-Mateos E; Ruiz-León MJ; Tarancón-Díez L; Gutiérrez C; Dronda F; Domínguez-Molina B; Pérez-Elías MJ; Moreno A; Leal M; Moreno S; Vallejo A
    Virus Res; 2019 Apr; 264():40-44. PubMed ID: 30776394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HCV/HTLV coinfection: Does HTLV-1 interfere in the natural history of HCV-related diseases?
    Silva MC; Silva CA; Machado GU; Atta A; M Freire S; Carvalho E; Schinoni MI; Paraná R
    J Med Virol; 2016 Nov; 88(11):1967-72. PubMed ID: 27027482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of human T-lymphotropic virus type 1 coinfection on the development of hepatocellular carcinoma in patients with hepatitis C virus infection.
    Tokunaga M; Uto H; Oda K; Tokunaga M; Mawatari S; Kumagai K; Haraguchi K; Oketani M; Ido A; Ohnou N; Utsunomiya A; Tsubouchi H
    J Gastroenterol; 2014 Dec; 49(12):1567-77. PubMed ID: 24463696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis C virus and human T-lymphotropic virus coinfection: epidemiological, clinical, laboratory and histopathological features.
    Milagres FA; Duarte MI; Viso AT; Segurado AC
    Rev Soc Bras Med Trop; 2009; 42(4):363-8. PubMed ID: 19802468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of correlation between HIV viral load and CD4+ T-cell counts in HIV/HTLV-1 co-infection in treatment naive Mozambican patients.
    Bhatt NB; Gudo ES; Semá C; Bila D; Di Mattei P; Augusto O; Garsia R; Jani IV
    Int J STD AIDS; 2009 Dec; 20(12):863-8. PubMed ID: 19948902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular epidemiology of HIV, HBV, HCV, and HTLV-1/2 in drug abuser inmates in central Javan prisons, Indonesia.
    Prasetyo AA; Dirgahayu P; Sari Y; Hudiyono H; Kageyama S
    J Infect Dev Ctries; 2013 Jun; 7(6):453-67. PubMed ID: 23771289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human T lymphotropic virus type 1 infection influences hepatitis C virus clearance.
    Kishihara Y; Furusyo N; Kashiwagi K; Mitsutake A; Kashiwagi S; Hayashi J
    J Infect Dis; 2001 Nov; 184(9):1114-9. PubMed ID: 11598833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibody to the human T-lymphotropic virus type 1 (HTLV-1) envelope protein Gp46 in patients co-infected with HCV and HTLV-1.
    Takeoka H; Furusyo N; Toyoda K; Murata M; Sagara Y; Kashiwagi S; Hayashi J
    Am J Trop Med Hyg; 2007 Jul; 77(1):192-6. PubMed ID: 17620653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased prevalence of HTLV-I infection in patients with hepatocellular carcinoma associated with hepatitis C virus.
    Okayama A; Maruyama T; Tachibana N; Hayashi K; Kitamura T; Mueller N; Tsubouchi H
    Jpn J Cancer Res; 1995 Jan; 86(1):1-4. PubMed ID: 7737899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Making the invisible visible: searching for human T-cell lymphotropic virus types 1 and 2 (HTLV-1 and HTLV-2) in Brazilian patients with viral hepatitis B and C.
    Caterino-de-Araujo A; Alves FA; Campos KR; Lemos MF; Moreira RC
    Mem Inst Oswaldo Cruz; 2018 Feb; 113(2):130-134. PubMed ID: 29236927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis C virus infection and spontaneous clearance in HTLV-1 and HIV co-infected patients in Salvador, Bahia, Brazil.
    Le Marchand C; Bahia F; Page K; Brites C
    Braz J Infect Dis; 2015; 19(5):486-91. PubMed ID: 26254690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Seroprevalence of HIV, HBV, HCV, and HTLV among Pregnant Women in Southwestern Nigeria.
    Opaleye OO; Igboama MC; Ojo JA; Odewale G
    J Immunoassay Immunochem; 2016; 37(1):29-42. PubMed ID: 25879258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of HTLV-1/2 infections in Spain: A cross-sectional hospital-based survey.
    Treviño A; García J; de Mendoza C; Benito R; Aguilera A; Ortíz de Lejarazu R; Ramos JM; Trigo M; Eirós JM; Rodríguez-Iglesias M; Torres A; Calderón E; Hernandez A; Gomez C; Marcaida G; Soriano V;
    AIDS Res Hum Retroviruses; 2010 Aug; 26(8):861-4. PubMed ID: 20672999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delayed liver fibrosis in HTLV-2-infected patients co-infected with HIV-1 and hepatitis C virus with suppressive antiretroviral therapy.
    Abad-Fernández M; Moreno A; Dronda F; del Campo S; Quereda C; Casado JL; Pérez-Elías MJ; Moreno S; Vallejo A
    AIDS; 2015 Feb; 29(4):401-9. PubMed ID: 25565497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative study of impulsiveness and risk behaviors among infected individuals with hepatitis C virus and human T-cell lymphotropic virus type 1.
    Henrique-Araújo R; Quarantini LC; Morais-de-Jesus M; Jesus-Nunes AP; Dantas-Duarte A; Caribé AC; Argolo FC; Marback RF; Costa TV; Oliveira IR
    Ann Hepatol; 2020; 19(2):166-171. PubMed ID: 31711914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short Communication: Current Prevalence and Risk Factors Associated with Human T Lymphotropic Virus Type 1 and Human T Lymphotropic Virus Type 2 Infections Among HIV/AIDS Patients in São Paulo, Brazil.
    Caterino-de-Araujo A; Sacchi CT; Gonçalves MG; Campos KR; Magri MC; Alencar WK;
    AIDS Res Hum Retroviruses; 2015 May; 31(5):543-9. PubMed ID: 25464979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis C virus genetic variability in 52 human immunodeficiency virus-coinfected patients.
    Neau D; Jouvencel AC; Legrand E; Trimoulet P; Galperine T; Chitty I; Ventura M; Le Bail B; Morlat P; Lacut JY; Ragnaud JM; Dupon M; Fleury H; Lafon ME
    J Med Virol; 2003 Sep; 71(1):41-8. PubMed ID: 12858407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.